Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Clovis Oncology Inc (NASDAQ: CLVS)

$57.89 USD -$0.32 (-0.55%)
Last Price $57.89
Net Change $-0.32 (-0.55%)
Bid $0
Ask Price $0
Open Price $58.33
Previous Close Price $58.21
High Price $59.24
Low Price $56.76
Number of Trades 6,938
Volume 1,237,182
Fifty Two Week High $74.94 (2017-03-16)
Fifty Two Week Low $11.57 (2016-06-27)
Average Daily Volume 2,126,600
Share Outstanding 44,630 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-1.83 (2017-02-22)
2nd Quarter Earnings $-1.7 (2016-11-03)
3nd Quarter Earnings $-2.07 (2016-08-08)
4th Quarter Earnings $-2.17 (2016-05-05)
PE Ratio $0
EPS Growth $32.82
Recent Earnings $-1.83
Annual EPS $-7.77
Last Quarter EPS $
Market Capitalization $2.58B
Insider Shareholders % 0.174%
Annual Revenue $0B
No. Shares Outstanding 44,630
Inst. Shareholder % 84.57%
Annual Net Income $0B
TTM Net Profit Margin $102.66
1-Year Return 316.18%
3-Year Return 7.06%
5-Year Return 222.87%
5-Year Revenue Growth 0%
5-Year Earnings Growth -46.19%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 32.82%
Dividends per Share $
Stock Split Ratio
Beta 1.75
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.